
Share
As healthcare costs continue to burden American families, a new approach from federal regulators focuses on patient empowerment and transparency over insurance coverage alone.
Healthcare spending is one of the most significant financial burdens facing Americans, according to Casey Mulligan, chief economist and chief regulatory officer at the Department of Health and Human Services (HHS). Speaking at the HFMA Annual Conference in National Harbor, Maryland, Mulligan emphasized that making healthcare more affordable requires a shift in focus from insurance coverage to healthcare delivery.
Mulligan, appointed by HHS Secretary Robert F. Kennedy Jr. In April, is leading efforts to rethink how healthcare is delivered and paid for. His approach, which he calls "supply-side health economics," distinguishes between healthcare, health outcomes, and health insurance. This framework argues that while insurance is important, it's not the end goal. The real aim should be better health at lower costs, with more control in the hands of patients and families.
“Yes, insurance matters, but it’s not the endpoint,” Mulligan declared. “The endpoint is better health and lower costs with more control in the hands of patients and families.”
Mulligan believes that policymakers have spent too much time debating insurance coverage and not enough on addressing the underlying drivers of patient outcomes and healthcare costs. He advocates for giving patients more information, control over their health data, transparent pricing, genuine healthcare choices, and the freedom to evaluate competing medical claims.
To illustrate this point, consider a scenario where you need to buy groceries. You wouldn't just focus on getting a discount card; you'd also want to know the prices of items, compare different stores, and make informed decisions based on quality and cost. Similarly, in healthcare, patients should have access to clear information about their treatment options and costs.
One of Mulligan's primary responsibilities at HHS is conducting regulatory impact analysis. This involves carefully measuring the costs and benefits of policy decisions, as well as understanding who bears those costs and how incentives are created. For example, if a new regulation makes it easier for patients to access their health data, policymakers need to consider not just the immediate benefits but also potential long-term impacts on patient care and provider practices.
Mulligan has also closely examined provider taxes and state-directed payments. Many states use a financing mechanism where they tax hospitals, nursing homes, or managed-care plans, and then use this tax revenue to draw additional federal Medicaid matching funds. The combined funds are often returned to providers through various mechanisms. Mulligan argues that this system can distort market dynamics and potentially increase costs for patients.
A recent survey by the American Hospital Association (AHA) found that 80% of small business owners believe hospital prices, rather than insurance practices, are the primary driver of rising healthcare costs in America. This aligns with Mulligan's perspective that addressing the root causes of high healthcare costs is crucial.

Mulligan’s approach to making healthcare more affordable emphasizes transparency and patient empowerment. He believes that patients should have access to their own health data, transparent pricing information, and genuine choices in their care. This would allow them to make informed decisions about their health, similar to how they might choose a car or a home.
For instance, imagine you're shopping for a new car. You wouldn't just buy the first one you see; you'd research different models, compare prices, read reviews, and test drive several options before making a decision. The same should be true for healthcare. Patients should have the tools to compare different providers, treatments, and costs, enabling them to make choices that best meet their needs and budget.
Mulligan also advocates for reducing administrative burdens in healthcare. By simplifying workflows and focusing on human needs, healthcare providers can create more space for meaningful interactions between clinicians and patients. This could lead to better health outcomes and a more satisfying healthcare experience for everyone involved.
The implications of Mulligan’s approach are significant for both individuals and the broader healthcare system. By shifting the focus from insurance coverage to healthcare delivery, policymakers can address the root causes of high healthcare costs and improve patient outcomes. This could lead to more affordable care, greater transparency, and increased control for patients.
Ultimately, making healthcare more accessible and affordable is not just a policy issue; it's a matter of public health and economic well-being. By empowering patients with information and choices, we can create a healthcare system that truly serves the needs of all Americans.
Tags
Original Sources
HHS Affordability Czar Says Healthcare Costs Stem From Incentives, Not Coverage - MedCity News
↗ https://medcitynews.com/2026/06/hhs-affordability-healthcare-costs
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
15 June 2026
67 articles
Related Articles

Stanford's Patient Panels Shape AI in Healthcare: A Voice for Real People
Health & Science · 4 min

When Patients and Hospitals Disagree on AI Prognosis: A Growing Divide in Healthcare
Health & Science · 4 min

AI in Drug Development: Realities and Hype According to BigHat Biosciences CEO
Health & Science · 3 min
Related Articles

Stanford's Patient Panels Shape AI in Healthcare: A Voice for Real People
Health & Science · 4 min

When Patients and Hospitals Disagree on AI Prognosis: A Growing Divide in Healthcare
Health & Science · 4 min

AI in Drug Development: Realities and Hype According to BigHat Biosciences CEO
Health & Science · 3 min
More Stories
© 2026 Cedar & Bloom. All rights reserved.